Kapoor, K.; Harris, K.; Arian, K.; Ma, L.; Church, K.; Kalluri, R.

Extracellular Vesicles (EVs) have emerged as potential biomarkers for diagnosing a range of diseases without invasive procedures. Extracellular vesicles also offer an advantage compared to synthetic vesicles, for delivery of various drugs. However, limitations in segregating EVs from soluble proteins have led to inconsistent EV retrieval rates with low levels of purity. Here, we report a new high-yield (>95%) and rapid (<20 min) EV isolation method called Size Exclusion Fast Performance Liquid Chromatography (SE FPLC). We show SE FPLC can effectively isolate EVs from multiple sources including EVs derived from human and mouse cells and serum. The results indicate that SE FPLC can successfully remove highly abundant protein contaminants such as albumin and lipoprotein complexes, which can represent a major hurdle in large scale isolation of EVs for clinical translation. Additionally, the high-yield nature of SE FPLC allows for easy industrial upscaling of extracellular vesicles production for various clinical utilities. Moreover, SE FPLC enables analysis of very small volumes of blood for use in point-of-care diagnostics in the clinic. Collectively, SE FPLC offers many advantages over current EV isolation methods and offers rapid clinical utility potential.